NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Daoyuan Precise Medical

Private
BeijingHealthcare & Life Sciences

Last Round

Series C

Jan 22, 2024

Total Funding Raised

$41.4M

Company Overview

Daoyuan Precise Medical is a healthtech company that develops and commercializes molecular imaging surgical navigation equipment and related tracer agents.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

liquid biopsyCTCcirculating tumor cellsdiagnostic instrumentsCTC enrichmentdiagnostic consumablescancer monitoringcancer diagnosisnon-invasive diagnosticsprecision medicinerazor and blades modelmedical devicesbiotechnologyvolume-based procurementVBP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Daoyuan Precise Medical Comps

Public and private peers based on sector, stage, and business model.

Daoyuan Precise Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Daoyuan Precise Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 22, 2024
Series B ExtensionDec 1, 2023
Series BJul 19, 2022
SeedDec 27, 2018

Daoyuan Precise Medical Investors

Notable investors and investment history

Daoyuan Precise Medical investors
InvestorRounds
Zhuhai Gree Financial Investment ManagementSeries B Extension
Chinese Academy of SciencesSeed
Zhongguancun Longmen InvestmentSeries B
Hyfinity InvestmentsSeries C
Rising CapitalSeries C
SB China CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2024

    $28M round led by Hyfinity Investments and Rising Capital.

  • Dec 1, 2023

    $13.4M round led by Zhuhai Gree Financial Investment Management.

Daoyuan Precise Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Daoyuan Precise Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Daoyuan Precise Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2016
Last FundingJan 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.